Just a few decades ago, the possibility of connecting the brain with a computer to convert neural signals into concrete actions would have seemed like something from science fiction.
But in recent years, some scientific advances have been made in this regard, through so-called BCIs (Bran-Computer Interfaces) that establish communication bridges between the human brain and computers.
A recent study by UPF continues to advance in this direction and makes new contributions to pursue this desired neuroscientific milestone.
The results of the study by the UPF Center for Brain and Cognition (CBC) are the subject of an article published on February 7 in the journal eNeuro, titled “Long-range alpha-synchronisation as control signal for BCI: A feasibility study,” jointly written by Martín Esparza-Iaizzo (UPF and University College of London), Salvador Soto-Faraco (UPF and ICREA), Irene Vigué-Guix (UPF), Mireia Torralba Cuello (UPF), and Manuela Ruzzoli (Basque Center on Cognition Brain and Language).
One of the main current challenges in neuroscience is the identification of brain signals which are robust enough to control devices in real time. Neuroscientists have already achieved devices that can be controlled with the mind using only the activity of one or several regions of the brain.
However, it is not yet possible to do so via the communication and synchronization of different regions of the brain. The article published by eNeuro makes significant contributions to advance in achieving this goal.
Brain activity during visuospatial attention tasks
This study is based on the analysis of the brain activity of 10 people during a visuospatial attention task, performing up to 200 measurements per subject, and relies on the concept of crossed laterality: what we see on the right hand side of the visual field is represented in the left hemisphere of the brain and, conversely, what we see on the left is represented in the right hemisphere.
Levels of the brain signal known as the alpha band decrease in the hemisphere in which the images we observe are represented. The researchers compare variations in alpha band levels to the plates on a weighing scale. It is precisely on the side of the scale in which more weight is loaded where their plates descend to a greater extent, while, on the side with less weight, they tend upwards.
The same goes for the levels of the alpha band: it is precisely in the hemisphere on the side where the images are represented that the levels of the alpha band decrease most, while they rise in the opposite hemisphere. It should be borne in mind that the alpha band inhibits the excitability of neurons, so it causes a state of relaxation of neuronal populations. It is therefore not surprising that their level is lower in the hemisphere of the brain that processes images.
It should also be noted that the brain is divided into different regions that communicate by synchronizing its neural fluctuations, for example in the alpha range. Precisely, one of the objectives of the research was to analyze whether the long-range synchronization of the alpha band between brain regions presents lateralized patterns and this has been confirmed by the study authors.
Specifically, if we attend to the right, the communication between the frontal and parietal regions of the left hemisphere increases and, if we attend to the left, the communication between these same regions in the right hemisphere increases.
To date, signals from the alpha band with which the brain’s frontal and parietal regions communicate can only be fully captured through the aggregation of data from different measurements and not through a single trial. Therefore, another of the objectives of the study was precisely to examine how to capture these neural patterns at a single test level, which would allow generating a control signal to activate devices through brain-computer interfaces in real time.
To achieve this, the principal investigator, Martín Esparza-Iaizzo explains that his study makes contributions from the methodological point of view: “The novelty of the study is that, unlike previous studies, it uses measures of synchrony between parietal and frontal areas at the level of each individual trial, not in aggregated data,”
However, he warns that the limitations of current electroencephalographs to achieve this goal have been noted:
“Current encephalography has limitations in terms of spatial resolution, and in terms of noise, due to breathing, heart activity, etc.”
However, the findings of this research provide a good basis for future research. In this sense, Esparza-Iaizzo concludes, “What our study presents is a good methodology to demonstrate that, indeed, for the time being, synchrony cannot be brought into the world of systems with real-time operation. We hope it will serve as a paradigm for future attempts.”
News
Engineered tRNAs and lipid nanoparticles target nonsense mutation cystic fibrosis
Researchers have developed a potential new approach for treating a form of cystic fibrosis caused by so-called nonsense mutations, combining chemically modified transfer RNAs with lipid nanoparticles designed to deliver the therapy directly to [...]
New pancreatic cancer drug carries a $39,800 monthly list price
A groundbreaking treatment for one of the most common forms of pancreatic cancer has been approved in pill form by the FDA. Revolution Medicines’ oral tablet daraxonrasib, branded as Rasonque, reduced the risk of [...]
Researchers Have Discovered a New Way To Reduce Chronic Nerve Pain
A cancer-linked protein called BRAF may help drive chronic nerve pain, and existing cancer drugs targeting it reduced pain sensitivity in preclinical models. Chronic nerve pain can persist long after an injury and often [...]
Our books now available worldwide!
Online Sellers other than Amazon, Routledge, and IOPP Indigo Global Health Care Equivalency in the Age of Nanotechnology, Nanomedicine and Artifcial Intelligence Global Health Care Equivalency In The Age Of Nanotechnology, Nanomedicine And Artificial [...]
Quantum-Enabled Regenerative Health: Reimagining Wellness, Precision Health and Longevity Medicine
Introduction Healthcare is approaching a frontier where the quantum portfolio could influence not only how disease is diagnosed and treated, but how health itself is measured, modeled, predicted and preserved. Quantum computing, quantum simulation, [...]
FDA Clears First-of-Its-Kind Nonmedication Treatment for PTSD
The FDA has cleared a system that uses brain activity data to personalize magnetic stimulation for PTSD, adding a new nonmedication treatment option. Every day in the United States, approximately 17.5 veterans die by suicide, [...]
FDA approves breakthrough drug to treat advanced pancreatic cancer
The Food and Drug Administration (FDA) approved on Wednesday a drug that could extend the survival of those with metastatic pancreatic cancer. The drug, called daraxonrasib, will be sold under the brand name Rasonque [...]
AI Decodes a Hidden DNA Signal Linked to Disease-Causing Mutations
Machine learning identifies the likely “initiator” and enables new predictions about DNA mutations that can cause disease. Every human cell depends on tens of thousands of genes being switched on at the right time [...]
Pope Leo Urges Global Response to Congo’s Deadliest Ebola Outbreak
Pope Leo called for international action to address the Ebola outbreak in the Democratic Republic of Congo. The epidemic has claimed over 2,500 lives and is the nation's largest recorded outbreak. The Pope emphasized [...]
Is there a summer COVID-19 surge this year? Yep, it’s ramping up again
Hantavirus. Ebola. West Nile. Measles. And, of course, cyclospora — that stomach parasite making people miserable across the country. Americans have plenty to worry about this summer. But remember COVID-19? It may not be [...]
Natural Compound in Broccoli Could Help Treat a Rare, Incurable Neurological Disease
Swinburne researchers have discovered how broccoli could help treat an extremely rare and incurable disease that affects only about 200 Australians. A naturally occurring compound in broccoli is being investigated as a possible treatment [...]
Antibody recycling, FcRn and the next generation of biologics
FcRn plays a central role in regulating the half-life of IgG antibodies and albumin, making it a critical target in both antibody engineering and autoimmune disease therapy. This article explores the biology of FcRn, [...]
Ebola kills 2,300 in three months with no vaccine available for Congo’s deadliest ever outbreak
It’s Congo’s 17th outbreak, with a toll that has eclipsed that of the country’s 2018-2020 outbreak when 2,299 deaths out of 3,481 cases were recorded. The latest data shows 101 new cases and 33 [...]
Beyond an Agency: How AI, Creativity and Commercialization Are Converging Into a New Growth Model
At a moment when AI is forcing a fundamental rethink of how work gets done, the life sciences industry is grappling with a deeper question: what role should human creativity play in an increasingly [...]
New $60 Blood Test Detects Lung Cancer Without Costly DNA Sequencing
A simple blood test that detects chemical changes in DNA identified more than 90% of stage 2-4 lung cancers in an early study, without relying on costly DNA sequencing. Researchers at Tel Aviv University and collaborating [...]
Reducing drug development failures with human-relevant models and AI
Professor Joseph C. Wu of Stanford University explains how stem cells, human-relevant models and AI are helping researchers predict which drug candidates are most likely to succeed before clinical trials. Researchers now have access [...]















